Our patient presented with repetitive, self-limited bouts of forceful hiccups in sleep. Eszopiclone, a commonly prescribed hypnotic, appeared to cause these intermittent hiccups. This case is a reminder that eszopiclone may cause this adverse effect, and that it may be the bed partner and not the patient who furnishes critical sleep medicine history.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962880 | PMC |
| http://dx.doi.org/10.1136/bcr-2013-202365 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of Remimazolam-Flumazenil and Propofol on Psychomotor Function and Emergence Following General Anesthesia in Surgical Abortion: A Randomized Controlled Trial.
Drug Des Devel Ther
January 2025
Department of Anesthesiology, Ningbo No. 2 hospital, Ningbo, 315010, People's Republic of China.
Objective: This study aims to compare the recovery profiles of remimazolam combined with flumazenil against those of propofol in patients undergoing painless surgical abortion, focusing on psychomotor function and emergence. Rapid recovery and restoration of psychomotor function are critical for enhancing patient safety and satisfaction in outpatient procedures like surgical abortion.
Methods: A total of 110 patients scheduled for surgical abortion were randomly assigned to either the remimazolam group (Group R) or the propofol group (Group P) in a 1:1 ratio.
Comparison of hypotension between propofol and remimazolam-propofol combinations sedation for day-surgery hysteroscopy: a prospective, randomized, controlled trial.
BMC Anesthesiol
October 2024
Department of Anesthesiology, Women's Hospital, Zhejiang University School of Medicine, Xueshi Road 1, Hangzhou, 310006, People's Republic of China.
Article Synopsis
- The study aimed to compare the effects of propofol alone versus a combination of remimazolam and propofol on hypotension during day-surgery hysteroscopy.
- Results indicated that hypotension occurred more frequently in the propofol group (20%) compared to the remimazolam-propofol group (7.2%).
- Additionally, the remimazolam-propofol combination required a lower total dose of propofol and was associated with fewer side effects, like injection pain and low oxygen saturation.
[Comparison of the efficacy of remimazolam and propofol on hemodynamics and quality of early postoperative recovery in elderly patients with frailty undergoing endoscopic retrograde cholangiopancreatography].
Zhonghua Yi Xue Za Zhi
August 2024
Department of Anesthesiology, General Hospital of Northern Theater Command, Shenyang 110016, China.
Article Synopsis
- The study compares the effectiveness of remimazolam and propofol in managing hemodynamics and postoperative recovery in elderly frail patients undergoing ERCP.
- A total of 108 patients were randomly assigned to either the remimazolam group or the propofol group, each receiving different dosages for anesthesia.
- Results showed that the remimazolam group had a significantly lower incidence of intraoperative hypotension (24.5%) compared to the propofol group (43.6%), although the difference in severe hypotension rates was not significant.
Effectiveness and safety of remimazolam tosilate versus propofol for sedation in patients undergoing gastrointestinal endoscopy: a randomized controlled trial.
Int J Clin Pharm
December 2024
The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, GanSu Province, China.
Background: Remimazolam tosilate is a new type of benzodiazepine currently used for gastrointestinal endoscopy and can be combined with alfentanil.
Aim: This trial compared the effectiveness and safety of remimazolam with alfentanil to propofol with alfentanil in patients undergoing gastrointestinal endoscopy.
Method: One hundred and sixty-six patients were randomly divided into propofol-alfentanil anaesthesia (Group P) and remimazolam-alfentanil anaesthesia (Group R).
Determination of the effective dose of remimazolam combined with sufentanil for inhibiting body movement during surgical abortion: An up-and-down sequential allocation trial.
Medicine (Baltimore)
July 2024
Department of Anesthesiology, Ningbo No. 2 Hospital, Ningbo, P. R. China.
Article Synopsis
- Remimazolam is a new anesthetic that's quick-acting and could be useful for painless surgical abortions, and this study aimed to find out how much of it is needed to prevent movement during the procedure.
- The study involved 25 healthy women in their first trimester, and they were given sufentanil first, followed by remimazolam to see the effective doses for ensuring stillness during surgery.
- Results suggested that the doses to inhibit body movement were around 0.145 mg/kg and 0.242 mg/kg, with patients generally recovering quickly—most being alert shortly after surgery.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!